BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Relief Therapeutics Forms Exclusive Agreement with Eton Pharmaceuticals for PKU GOLIKE in the U.S. Relief Therapeutics Eton Pharmaceuticals PKU GOLIKE Biopharmaceutical Partnership Rare Metabolic Diseases
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Relief Therapeutics conclut un accord exclusif avec Eton Pharmaceuticals pour la PKU GOLIKE aux États-Unis Thérapeutique De Soulagement Eton Pharmaceutique PCU GOLIKE Partenariat Biopharmaceutique Maladies Métaboliques Rares
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago CEWE Stiftung & Co. KGaA Announces Positive Financial Growth in 2023 and Optimistic Outlook for 2024 CEWE Stiftung & Co. KGaA Dividend Increase Photofinishing Financial Growth Online Printing
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago CEWE Stiftung & Co. KGaA annonce une croissance financière positive en 2023 et des perspectives optimistes pour 2024 Croissance Financière CEWE Stiftung & Co. KGaA Augmentation Du Dividende Finition Photo Impression En Ligne
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago ALSO Holding AG Announces Thirteenth Consecutive Dividend Increase Annual General Meeting Sustainable Growth Dividend Increase ALSO Holding AG Technology Provider
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago ALSO Holding AG annonce une treizième augmentation consécutive de son dividende Augmentation Du Dividende Assemblée Générale Annuelle ALSO Holding SA Fournisseur De Technologie Une Croissance Durable
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago BMW and World Woman Foundation Partner for 2024 'World Woman Hour' in Los Angeles Female Leadership Empowerment International Women's Day World Woman Hour BMW
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago BMW et la World Woman Foundation s'associent pour la « World Woman Hour » 2024 à Los Angeles Leadership Féminin Journée Internationale De La Femme Autonomisation Heure Mondiale De La Femme BMW
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Biophytis dévoile son étude de phase 3 sur le traitement de la sarcopénie Biophytis Sarcopénie Ruvembri Étude De Phase 3 ICFSR
BRIEF published on 03/22/2024 at 07:05, 1 year 8 months ago Biophytis Unveils Phase 3 Sarcopenia Treatment Protocol Biophytis Clinical Research RuvembriTM Sarcopenia Phase 3 Study
Published on 12/17/2025 at 15:00, 2 hours 12 minutes ago BlackBerry Unveils Ground-Up Modernization of BlackBerry AtHoc Mobile Experience to Enable More Intelligent Operations
Published on 12/17/2025 at 14:00, 3 hours 12 minutes ago UniDoc Completes H3 Health Cube Installation in Italy
Published on 12/17/2025 at 13:35, 3 hours 37 minutes ago Silver X Mining Announces Grant of Incentive Stock Options and Restricted Share Units
Published on 12/17/2025 at 13:15, 3 hours 57 minutes ago Aclara Wins UN Global Compact Award for Its Contribution to Local Employment and Suppliers
Published on 12/17/2025 at 13:00, 4 hours 12 minutes ago Gold Terra Provides a Summary of 2025 Achievements and 2026 Plan
Published on 12/17/2025 at 16:05, 1 hour 6 minutes ago TCL to Display the Future with Advanced Visual Innovations and AI-Powered Product Portfolio at CES 2026
Published on 12/17/2025 at 16:03, 1 hour 9 minutes ago 1&1 mobile network reaches 25 percent of German households
Published on 12/17/2025 at 15:32, 1 hour 39 minutes ago Fuller, Smith & Turner PLC: Director/PDMR Shareholding
Published on 12/16/2025 at 21:45, 19 hours 26 minutes ago Mise à disposition du rapport financier annuel
Published on 12/16/2025 at 20:10, 21 hours 1 minute ago donation of shares of Seval, member of the Feuillet family concert
Published on 12/16/2025 at 20:10, 21 hours 1 minute ago Donation de titres de la société Seval, membre du concert familial Feuillet
Published on 12/16/2025 at 18:53, 22 hours 18 minutes ago Number of shares and voting rights - November 2025 (In French only)
Published on 12/16/2025 at 18:53, 22 hours 18 minutes ago Nombre total d'actions et droits de vote - novembre 2025
